Parabilis Medicines, Inc. Common Stock(PBLS:US)
Market Cap$2.924B
Key Metrics
Price$24.75
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$329.04M
Total Assets$384.17M
Net Assets$244.22M
Total Debt$53.15M
Key Metrics
Price$24.75
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$329.04M
Total Assets$384.17M
Net Assets$244.22M
Total Debt$53.15M
Financials
| Name | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
Revenue | $0 | $0 |
Cost of Revenue | - | - |
Gross Profit | - | - |
| $47.45M | $40.24M | |
| Research and Development | $37.75M | $33.91M |
| Selling, General, and Administrative | $9.7M | $6.34M |
| Other Operating Expenses | - | - |
Operating Income | -$47.45M | -$40.24M |
| $2.14M | $1.92M | |
| Non-Operating Interest Income | $2.43M | $1.26M |
| Non-Operating Interest Expense | $292K | $399K |
| Other Income/Expense | - | $1.06M |
Income Before Tax | -$45.32M | -$38.33M |
Income Tax | - | - |
Net Income | -$45.32M | -$38.33M |
Minority Interests | - | - |
Preferred Stock Dividends | - | - |
Net Income to Common | -$45.32M | -$38.33M |
Shares Outstanding (Basic) | 80.4M | 80.4M |
Shares Outstanding (Diluted) | 80.4M | 80.4M |
EPS (Basic) | -$0.56 | -$0.60 |
EPS (Diluted) | -$0.56 | -$0.60 |
EBIT | -$45.02M | -$37.93M |
EBITDA | -$44.42M | -$37.27M |